Showing results (251-260 of 641) with videos related to
Sort By:
Pageof 65
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 2, 2004
Pharmacogenetic risk factors for osteonecrosis of the hip among children with leukemiaMary V Relling, Wenjian Yang, Soma Das, et al.Blood|December 15, 2010
Pharmacokinetic, pharmacodynamic, and pharmacogenetic determinants of osteonecrosis in children with acute lymphoblastic leukemiaJitesh D Kawedia, Sue C Kaste, Deqing Pei, et al.Blood|January 18, 2003
Granulocyte colony-stimulating factor and the risk of secondary myeloid malignancy after etoposide treatmentMary V Relling, James M Boyett, Javier G Blanco, et al.Pediatric Blood & Cancer|February 15, 2011
Neuropathic pain during treatment for childhood acute lymphoblastic leukemiaDoralina L Anghelescu, Lane G Faughnan, Sima Jeha, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 2002
Favorable impact of the t(9;11) in childhood acute myeloid leukemiaJeffrey E Rubnitz, Susana C Raimondi, Xin Tong, et al.Psychoneuroendocrinology|December 2, 2016
Association between dehydroepiandrosterone-sulfate and attention in long-term survivors of childhood acute lymphoblastic leukemia treated with only chemotherapyYin Ting Cheung, Wassim Chemaitilly, Daniel A Mulrooney, et al.Pediatric Blood & Cancer|August 18, 2005
Changes in bone mineral density in survivors of childhood acute lymphoblastic leukemiaSue C Kaste, Shesh N Rai, Katherine Fleming, et al.Pediatric Blood & Cancer|February 14, 2019
Bloodstream infections exacerbate incidence and severity of symptomatic glucocorticoid-induced osteonecrosisEmily R Finch, Laura J Janke, Colton A Smith, et al.Cancer Chemotherapy and Pharmacology|June 25, 2021
Pharmacodynamics of cerebrospinal fluid asparagine after asparaginaseJohn C Panetta, Yiwei Liu, Teodoro Bottiglieri, et al.Cancer|March 21, 2023
Clinical characteristics and outcomes of children with newly diagnosed acute myeloid leukemia and hyperleukocytosis managed with different cytoreductive methodsGeorgios E Christakopoulos, Kendra N Walker, Jesse Smith, et al.Pageof 65